Physical Activity to Mitigate PreEclampsia Risk
The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on…
Conditions studied
Pre-Eclampsia
About this study
The purpose of this study is to compare the effects of aerobic (AE), resistance (RE), and combination (AERE) exercise throughout pregnancy on selected maternal and fetal/neonatal physiological variables in women at-risk for preeclampsia. The central hypothesis of this project is that exercise will decrease severity and occurrence of preeclampsia symptoms, thus improving maternal, pregnancy, and birth outcomes. Aim 1. Determine the influence of different exercise modes during pregnancy at risk of preeclampsia on maternal cardiometabolic health. Aim 2. Determine the most effective exercise mode in pregnancy at risk of preeclampsia on improving birth and infant health outcomes.
Interventions
- Behavioral: Exercise Modes — Moderate intensity aerobic exercise Moderate intensity resistance exercise Moderate intensity combination exercise
Primary outcomes
- Systolic Blood Pressure (16wks) (16 weeks gestation)
- Systolic Blood Pressure (20wks) (20 weeks gestation)
- Systolic Blood Pressure (24wks) (24 weeks gestation)
- Systolic Blood Pressure (28wks) (28 weeks gestation)
- Systolic Blood Pressure (32wks) (32 weeks gestation)
- Systolic Blood Pressure (36wks) (36 weeks gestation)
- Maternal Cardiometabolic Risk (CMR) Score (during pregnancy)
- Symptom Occurrence (at delivery)
Eligibility information
Study locations
- East Carolina University, Greenville, North Carolina 27834 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.